InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Sinclair Andrew, Director. Director active across 3 companies, notably Adicet Bio, Inc.. In total, 8 disclosures have been published. Split: 5 buys · 0 sell. Total volume traded: €24.8m. History available since 8 December 2021. The latest transaction was disclosed on 1 July 2022 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
1,314,127 shares@ US$55.0091.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-018397:0
7,720,000 sharesCommon StockSEC:0000905718-22-000521:0
Ideal exit: 24 Dec 2022 (T+270)
287,471 shares@ US$13.204.5% of flowCommon Stock, $0.001 par valueSEC:0000905718-22-000178:0
287,471 shares@ US$13.20100.0% of flowCommon Stock, $0.001 par valueSEC:0000905718-22-000178
500,000 shares@ US$14.007.69% mcap25.0% of flowCommon StockSEC:0000905718-21-001591:0
Ideal exit: 4 Sept 2022 (T+270)
500,000 shares@ US$14.007.69% mcap50.0% of flowCommon StockSEC:0000905718-21-001591
Ideal exit: 4 Sept 2022 (T+270)
500,000 shares@ US$14.007.69% mcap25.0% of flowCommon StockSEC:0000905718-21-001587:0
Ideal exit: 4 Sept 2022 (T+270)
500,000 shares@ US$14.007.69% mcap50.0% of flowCommon StockSEC:0000905718-21-001587
Ideal exit: 4 Sept 2022 (T+270)
8 of 8 declarations
About Sinclair Andrew
Andrew Sinclair is a Board Member at Adicet Bio, Inc., Sierra Oncology, Inc., and Soleno Therapeutics Inc. He contributes to corporate governance and strategic decision-making for these companies.
